Health CanadaType I
Accupril Tabs: Nitrosamine impurity
Published: April 20, 2022Recall ID: 64095Category: generalCountry: Canada
Reason for Recall / Hazard
Contamination
Product Description & Identification
Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition may pose a greater health risk.Contact your health care provider to discuss other treatment options. There is currently a reduced supply of combination quinapril hydrochloride and hydrochlorothiazide nationally; however, other drug products are available for treating high blood pressure.If you have questions about the recall, contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries, and at 1-800-387-4974 for general inquiries.Report any health product-related side effects or complaints to Health Canada.
Affected Products
Accupril Tabs
Additional Source Details
| Field | Value |
|---|---|
| N I D | 64095 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/accupril-tabs-nitrosamine-impurity |
| Issue | Contamination |
| Title | Accupril Tabs: Nitrosamine impurity |
| Product | Accupril Tabs |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2022-04-20 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition may pose a greater health risk.Contact your health care provider to discuss other treatment options. There is currently a reduced supply of combination quinapril hydrochloride and hydrochlorothiazide nationally; however, other drug products are available for treating high blood pressure.If you have questions about the recall, contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries, and at 1-800-387-4974 for general inquiries.Report any health product-related side effects or complaints to Health Canada. |